New Inflammatory Marker Predicts Heart Disease Risk Better Than Single Tests
Chinese study of 4,157 adults finds cumulative CTI index outperforms single measurements for cardiovascular risk prediction.
Summary
Researchers analyzed data from 4,157 middle-aged and older Chinese adults over 9 years, finding that cumulative exposure to the C-reactive protein-triglyceride-glucose (CTI) index better predicts cardiovascular disease risk than single measurements. The CTI combines inflammation and metabolic markers. Participants with sustained high CTI levels had 31% higher cardiovascular risk. This cost-effective biomarker could improve early identification of high-risk individuals, particularly valuable in resource-limited healthcare settings.
Detailed Summary
A groundbreaking nationwide Chinese study reveals that tracking inflammatory and metabolic markers over time provides superior cardiovascular disease prediction compared to single-point measurements. The research introduces a novel approach using the cumulative C-reactive protein-triglyceride-glucose index (cuCTI) to assess long-term cardiovascular risk.
Researchers analyzed 4,157 middle-aged and older Chinese adults from the China Health and Retirement Longitudinal Study over 9 years (2011-2020). They calculated the CTI by combining C-reactive protein (inflammation marker) with triglycerides and glucose (metabolic markers), then tracked cumulative exposure and dynamic changes over time. During follow-up, 609 participants (14.6%) developed cardiovascular disease.
The results were striking: participants in the highest cuCTI tertile had significantly elevated cardiovascular risk compared to the lowest tertile (HR 1.36, 95% CI 1.07-1.74, p=0.014). Those with persistently high and increasing CTI trajectories showed 31% higher cardiovascular disease risk (HR 1.31, 95% CI 1.01-1.70, p=0.041). The study revealed a clear dose-response relationship - CVD incidence rates were 9.8%, 16.9%, and 17.4% across increasing cuCTI tertiles.
This research addresses a critical gap in cardiovascular risk assessment. While previous studies relied on single-time measurements, this longitudinal approach captures the cumulative burden of chronic inflammation and metabolic dysfunction. The CTI integrates two key pathways driving residual cardiovascular risk that persist despite managing traditional risk factors like cholesterol and blood pressure.
The clinical implications are significant. The cuCTI provides a cost-effective, accessible tool for cardiovascular risk stratification using routine laboratory tests. Healthcare providers could monitor CTI trajectories to identify high-risk patients earlier and implement targeted interventions. This approach may be particularly valuable in resource-limited settings where expensive imaging or specialized tests aren't readily available.
Key Findings
- Participants in highest cuCTI tertile had 36% increased cardiovascular disease risk vs lowest tertile (HR 1.36, 95% CI 1.07-1.74, p=0.014)
- Those with persistently high CTI trajectories showed 31% higher CVD risk compared to consistently low levels (HR 1.31, 95% CI 1.01-1.70, p=0.041)
- CVD incidence rates increased across cuCTI tertiles: 9.8% (Q1), 16.9% (Q2), and 17.4% (Q3), showing clear dose-response relationship
- Study followed 4,157 middle-aged and older Chinese adults for 9 years, with 609 participants (14.6%) developing cardiovascular disease
- Restricted cubic spline analysis revealed linear association between cumulative CTI exposure and cardiovascular disease risk (p<0.05)
- K-means clustering identified three distinct CTI trajectory patterns: consistently low, moderate, and persistently high/increasing levels
- Results remained consistent across all subgroups in sensitivity analyses, with no significant interactions by age, sex, or comorbidities
Methodology
Longitudinal cohort study using China Health and Retirement Longitudinal Study data from 2011-2020. Researchers calculated CTI using formula: 0.412 × ln(CRP) + ln(TG × FPG)/2, then computed cumulative exposure over 3-year intervals. Cox regression models with restricted cubic splines assessed dose-response relationships, while K-means clustering identified trajectory patterns. Multiple sensitivity analyses validated findings.
Study Limitations
Study limited to Chinese population, potentially limiting generalizability to other ethnicities. CVD diagnosis relied on self-reported physician diagnosis rather than objective clinical criteria. Some participants had missing follow-up data. Authors noted potential residual confounding despite extensive adjustment for covariates. No conflicts of interest reported.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.